Cargando…
Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial
Background: Until now, there have been no randomized controlled trials directly evaluating the efficacy of high-dose ilaprazole-amoxicillin dual therapy (HT) in comparison to other standard treatments for H. pylori (Helicobacter pylori) infection. This study aimed to compare the effectiveness and sa...
Autores principales: | Cheng, Jianping, Fan, Chanjuan, Huang, Kun, Zhai, Lili, Wang, Hui, Xie, Dongling, Cai, Yong, Li, Zhen, Bai, Qixuan, Wang, Pan, Ding, Haiou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661892/ https://www.ncbi.nlm.nih.gov/pubmed/38026958 http://dx.doi.org/10.3389/fphar.2023.1272744 |
Ejemplares similares
-
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022) -
High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
por: Kwack, WonGun, et al.
Publicado: (2016) -
14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial
por: Yang, Qinyu, et al.
Publicado: (2023) -
Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
por: Ahn, Hyo Jun, et al.
Publicado: (2017) -
Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial
por: Zhang, Xiao-Dong, et al.
Publicado: (2023)